Correlation Between Eupraxia Pharmaceuticals and Silo Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Silo Pharma, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Silo Pharma.

Diversification Opportunities for Eupraxia Pharmaceuticals and Silo Pharma

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eupraxia and Silo is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Silo Pharma go up and down completely randomly.

Pair Corralation between Eupraxia Pharmaceuticals and Silo Pharma

Given the investment horizon of 90 days Eupraxia Pharmaceuticals Common is expected to generate 1.11 times more return on investment than Silo Pharma. However, Eupraxia Pharmaceuticals is 1.11 times more volatile than Silo Pharma. It trades about 0.09 of its potential returns per unit of risk. Silo Pharma is currently generating about -0.01 per unit of risk. If you would invest  310.00  in Eupraxia Pharmaceuticals Common on September 2, 2024 and sell it today you would earn a total of  25.00  from holding Eupraxia Pharmaceuticals Common or generate 8.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eupraxia Pharmaceuticals Commo  vs.  Silo Pharma

 Performance 
       Timeline  
Eupraxia Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

Eupraxia Pharmaceuticals and Silo Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eupraxia Pharmaceuticals and Silo Pharma

The main advantage of trading using opposite Eupraxia Pharmaceuticals and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.
The idea behind Eupraxia Pharmaceuticals Common and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings